MRC1 and endometrial cancer: Pathogenic germline variants can also increase the likelihood of somatic biallelic inactivation in the same gene or somatic alterations in the same pathway.18,34 Concordantly, we found that endometrial cancer developing in carriers of pathogenic MMR variants had higher somatic variant rates in the MMR genes.